Evidence map›Paper›PMID 24163278›Full record

ReviewInternational journal of epidemiology2014

Substance use disorders and psychiatric comorbidity in mid and later life: a review.

Li-Tzy Wu, Dan G Blazer

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 3 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 3 syntheses or guidelines pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Collaborative Care for Psychiatric Disorders in Older Adults: A Systematic Review.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2017
    Pooled it
  4. Trial
  5. Prevalence, Correlates, and Treatment of Major Depression Among Community-Dwelling Adults Aged ≥50 in the US.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Features of Residential Counties and Individual Health Conditions for Opioid Use Disorder Among Older Medicare Beneficiaries.The journals of gerontology. Series B, Psychological sciences and social sciences · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Trends in Geographic Proximity to Substance Use Disorder Treatment.American journal of preventive medicine · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Li-Tzy WuDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
Dan G Blazer
Duke Medical Center · USDuke University Hospital · US

Funding

MDMA and Other Hallucinogen Use: Onset and Abuse/DependenceR01DA019623 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2007 to 2013
$1.1M
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN StudiesR33DA027503 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2010 to 2012
$1.1M
Epdemiology of Non-Medical Prescription Anagesic UseR01DA019901 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2007 to 2009
$416k
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN StudiesR21DA027503 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2009 to 2009
$302k
NIDA NIH HHS R01 DA019623NIDA NIH HHS R01DA019623NIDA NIH HHS R01 DA019901NIDA NIH HHS R01DA019901NIDA NIH HHS R21 DA027503NIDA NIH HHS R21DA027503NIDA NIH HHS R33 DA027503NIDA NIH HHS R33DA027503PHS HHS HSN271200522071C
6 · The paper itself

Abstract

backgroundGlobally, adults aged 65 years or older will increase from 516 million in 2009 to an estimated 1.53 billion in 2050. Due to substance use at earlier ages that may continue into later life, and ageing-related changes in medical conditions, older substance users are at risk for substance-related consequences.

methodsMEDLINE and PsychInfo databases were searched using keywords: alcohol use disorder, drug use disorder, drug misuse, substance use disorder, prescription drug abuse, and substance abuse. Using the related-articles link, additional articles were screened for inclusion. This review focused on original studies published between 2005 and 2013 to reflect recent trends in substance use disorders. Studies on psychiatric comorbidity were also reviewed to inform treatment needs for older adults with a substance use disorder.

resultsAmong community non-institutionalized adults aged 50+ years, about 60% used alcohol, 3% used illicit drugs and 1-2% used nonmedical prescription drugs in the past year. Among adults aged 50+, about 5% of men and 1.4% of women had a past-year alcohol use disorder. Among alcohol users, about one in 14 users aged 50-64 had a past-year alcohol use disorder vs one in 30 elder users aged 65+. Among drug users aged 50+, approximately 10-12% had a drug use disorder. Similar to depressive and anxiety disorders, substance use disorders were among the common psychiatric disorders among older adults. Older drug users in methadone maintenance treatment exhibited multiple psychiatric or medical conditions. There have been increases in treatment admissions for illicit and prescription drug problems in the United States.

conclusionsSubstance use in late life requires surveillance and research, including tracking substance use in the racial/ethnic populations and developing effective care models to address comorbid medical and mental health problems.

Indexed as

AgedDiagnosis, Dual (Psychiatry)FemaleGlobal HealthHumansIncidenceMaleMental DisordersMiddle AgedSubstance-Related DisorderscomorbidityEpidemiologyolder adultssubstance use disorders

Identifiers

PMID24163278
PMCPMC3997371
OpenAlexW2105035516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.